Tag Archives: ESC

Tales From the Road – European Society of Cardiology (ESC) in Barcelona

The last three and a half days exhibiting and demonstrating our EECP® Therapy and Biox products at the European Society of Cardiology (ESC) in Barcelona were extremely busy, slightly challenging at times, and very, very rewarding. Attendee traffic at our booth was very good due to a number of factors but especially the pre-show preparation which included setting up key meeting with prospective customers and mailing invitations to distributors, physicians, hospital and government personnel to visit our booth. Visitors enjoyed the opportunity to learn about our company, our products and how we can help them meet the challenges of providing more cost-effective healthcare to a rapidly growing and aging patient population in their respective countries.

Bolstered by the inclusion, for the first time, of EECP® Therapy in the ESC guidelines on the management of stable coronary artery disease with a IIa class recommendation, we received a significant amount of new and renewed interest in EECP® Therapy. In the addenda to the writing committees, after they had reviewed the large volume of clinical literature regarding EECP® Therapy, stated, “The results of these studies proving the concept and clinical effects of EECP treatment lead to the recommendation that EECP Therapy should be considered for symptomatic treatment in patients with invalidating refractory angina.”

In addition, a poster, entitled the “Long-term clinical outcomes in patients with coronary artery disease and moderate angina pectoris treated with enhanced external counterpulsation” by Dr. Ozlem Soran, et al, from the University of Pittsburgh Medical, Pittsburg, PA, was presented in this year’s ESC annual meeting. In the abstract, the authors summarized the clinical benefits by stating that “Patients presenting for EECP treatment with class II angina had different baseline profiles compared with Class III and IV angina. However, both cohorts achieved substantial reduction in angina with high event free survival rates at 2 years.”

There was considerable interest shown by both cardiologists as well as the administrators of hospitals, clinics and private physician practices in the company’s latest offering, the MobiCare™ wireless vital signs patient monitor. The comprehensive monitoring features and the unique communications capabilities of MobiCare™ provide clinician with accurate patient information and optimal flexibility to view the patient’s vital signs remotely on a tablet or smart phone.

Supported by our colleagues from Biox as well as personnel from our European and Korean distributors, the exhibition booth, though very busy at times, was well covered and it soon became customary to hear at least three or four foreign languages spoken in the booth simultaneously.

During the exhibition we closed multiple sales deals, including the sale of the Lumenair™ EECP® Therapy system used for live demonstrations in the show right out of the booth.

Tales from the Road: Vasomedical Visits Amsterdam for ESC Conference

We just recently returned from the 2013 European Society of Cardiology Congress (ESC) which was held in Amsterdam, the Netherlands this year. It was an enjoyable and rewarding trip for many reasons.

First, the ESC issued new guidelines for the treatment of stable angina and assigned EECP® Therapy a lla Level of Recommendation with a B Level of Evidence. The inclusion of EECP Therapy in the guidelines provides not only recognition of the Therapy by the European cardiology community, but the recommendation that it should be considered when treating refractory angina patients.

This news brought many visitors to our exhibit booth. They came to see what the Therapy looked like in person and see exactly how it operated. We had a live model and our Clinical Manager, Bill Seychell, providing live demonstrations. Additionally, as the crowds grew in the aisles surrounding our booth, it presented a great opportunity for visitors to learn about the additional products we were displaying, including the Biox ECG Holter and ambulatory blood pressure monitoring and our EZ patient monitoring products line.

Additionally, the two abstracts presented on EECP Therapy – one by Eline Wu, RN from the Karolinska Institute in Stockholm, the other by Dr. Vyacheslav Ryabov from Tomsk, Russia – were well received and motivated more visitors to visit our booth.

Amsterdam is a beautiful city and we were lucky to check out some of the great sites it has to offer, such as the National Museum, which had just returned to its newly renovated site.  We were able to get close and view the many famous paintings in its collection, including Rembrandt’s Night Watch.

One can go from one end of the spectrum to the other easily in Amsterdam – from the sobriety of Anne Frank’s House Museum to the fun and enjoyment of the Heineken Experience, Old Town streets, coffee houses, restaurants and shops. The beauty and uniqueness of the city is easily seen from a canal boat ride, a bicycle or a walk through the markets and squares. Just be careful not to get run over by the hundreds of cyclists who fill the bike lanes and speed down the sidewalks!